Maxwellia is a self-care company based in Alderley Park, UK, founded in 2013 by CEO Anna Maxwell, a pharmacist with over 20 years' experience. The company focuses on converting prescription-only medicines into pharmacy-available products and currently has three applications under assessment with the MHRA. It is awaiting approval of a women’s health product following a public consultation. Maxwellia intends to use new funding to scale up manufacture and rollout of its drugs following MHRA approval, invest in marketing, and expand its team. The company raised £3.2m in funding to support those plans. As part of the funding, Praetura Ventures’ director Dr Andy Round joined Maxwellia as a non-executive director.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2021